Table 1.
Participants in HAPIN throughout gestation.
| Treatment Group | Control | Intervention | Total | ||||||
|---|---|---|---|---|---|---|---|---|---|
| IRC | Guatemala | India | Peru | Rwanda | Guatemala | India | Peru | Rwanda | |
| Enrolled women (N) | 400 | 399 | 402 | 404 | 400 | 400 | 396 | 394 | 3195 |
| Exits before birth (N) | 14 | 13 | 44 | 10 | 16 | 12 | 11 | 15 | 135 |
| Live births (N) | 386 | 386 | 358 | 394 | 384 | 388 | 385 | 379 | 3060 |
| Days in study during pregnancy (randomization to the end of gestation): median (Q1, Q3) | 164.0 (144.8, 181.0) |
156.0 (136.5, 172.5) |
160.0 (136.0, 180.0) |
171.0 (154.0, 185.0) |
162.0 (143.0, 178.0) |
155.0 (136.0, 171.0) |
158.0 (138.0, 180.0) |
166.0 (152.0, 182.0) |
162.0 (142.0, 179.0) |
| Household size: median (Q1, Q3) | 4 (3, 6) |
3 (3, 5) |
4 (3, 6) |
3 (3, 4) |
5 (3, 7) |
3.5 (3, 5) |
4 (3, 5) |
3 (2, 4) |
4 (3, 5) |